Visceral adiposity as a predictor of survival in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy.

被引：2
|
作者：
Staley, Stuart-Allison Moffat
Tucker, Katherine
Oldan, Jorge
Moore, Dominic T.
Newton, Meredith
Ertel, Michelle
West, Lindsay
Bae-Jump, Victoria
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Div Gynecol Oncol, Chapel Hill, NC 27515 USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Biostat & Data Management, Chapel Hill, NC 27515 USA
[5] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e17031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17031
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dihydrofolate reductase as a predictor for poor response to platinum-based chemotherapy in epithelial ovarian cancer
    Wang, Min
    Hu, Ting
    Xie, Ke-Yu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (05): : 1723 - 1730
  • [42] TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas
    Malisic, E.
    Jankovic, R.
    Jakovljevic, K.
    Radulovic, S.
    JOURNAL OF BUON, 2011, 16 (04): : 701 - 707
  • [43] In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer
    Poelcher, Martin
    Rudlowski, Christian
    Friedrichs, Nicolaus
    Mielich, Marieke
    Hoeller, Tobias
    Wolfgarten, Mathias
    Kuebler, Kirsten
    Buettner, Reinhard
    Kuhn, Walther
    Braun, Michael
    BMC CANCER, 2010, 10
  • [44] The Protective Effect of Curcumin on Hepatic Function in Cancer Patients Receiving Taxane-Based Chemotherapy: A Randomized Controlled Clinical Trial
    Ansari, Hourieh
    Hajigholami, Ali
    Abbasi, Danial
    MIDDLE EAST JOURNAL OF CANCER, 2023, 14 (03) : 405 - 412
  • [45] Assessment of chemotherapy-induced cognitive impairment: a prospective study of the cognitive effects of platinum/taxane-based chemotherapy in gynecologic cancer patients
    Hutchcraft, Megan
    Anderson-Mooney, Amelia
    Dressler, Emily
    Koehl, Lisa
    Schmitt, Frederick A.
    Shelton, Brent
    Gorski, Justin
    Baldwin, Lauren
    DeSimone, Christopher
    Gallion, Holly
    Ueland, Frederick
    Miller, Rachel
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S92 - S93
  • [46] Quantitative Research: Changes in Neurofilament Light, a Marker of Axonal Damage in Breast Cancer Patients Receiving Taxane-Based Chemotherapy
    Simonelli, Mary
    Zulewski, David
    NURSING RESEARCH, 2020, 69 (03) : E162 - E163
  • [47] In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer
    Martin Pölcher
    Christian Rudlowski
    Nicolaus Friedrichs
    Marieke Mielich
    Tobias Höller
    Mathias Wolfgarten
    Kirsten Kübler
    Reinhard Büttner
    Walther Kuhn
    Michael Braun
    BMC Cancer, 10
  • [48] Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy
    Eisenhauer, Eric L.
    Tew, William P.
    Levine, Douglas A.
    Lichtman, Stuart M.
    Brown, Carol L.
    Aghajanian, Carol
    Huh, Jae
    Barakat, Richard R.
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2007, 106 (02) : 381 - 387
  • [49] β3-tubulin is a good predictor of sensitivity to taxane-based neoadjuvant chemotherapy in primary breast cancer
    Youqun Xiang
    Yinlong Yang
    Guilong Guo
    Xiaoqu Hu
    Huxiang Zhang
    Xiaohua Zhang
    Yifei Pan
    Clinical and Experimental Medicine, 2016, 16 : 391 - 397
  • [50] Peripheral neuropathy and lifestyle factors in women with breast cancer receiving taxane-based chemotherapy: Pathway analysis
    Ellikci, Rabia
    Arslan, Selda
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2023, 66
12345